Ropeginterferon : Interesting Presentation by Dr... - MPN Voice

MPN Voice

10,445 members14,398 posts

Ropeginterferon

Paul123456 profile image
13 Replies

Interesting Presentation by Dr Verstovsek on the 24 months results for Ropeginterferon versus HU. Results have been known for several months but this Presentation fills in the detail. Looks very promising and the three year results now eagerly anticipated.

At end year 2, Ropeg (after a slow start) has now overtaken HU. Especially exciting is the improved molecular response which could (fingers crossed) slow progression.

Will this continue to improve in year 3 and will Ropeg continue to pull away from HU?

So far, side effects appear similar level to HU. Remember the problem with Interferon has been some patients really struggle with the side effects

youtube.com/watch?v=nDVFEnY...

Written by
Paul123456 profile image
Paul123456
To view profiles and participate in discussions please or .
Read more about...
13 Replies
EleanorPV profile image
EleanorPV

Looking forward to a release date, for the availability of ropeginterferon in the uk.

Poppy112 profile image
Poppy112

Very interesting watch, thank you for posting and look forward to further data as it becomes available.

Betsywest profile image
Betsywest

Hi Paul, sorry for my ignorance but is ropeginterferon the same as Pegasus interferon? Btw, thanks so much for always posting all this fab up to date information for us!

Paul123456 profile image
Paul123456 in reply to Betsywest

Ropeg is a derivative of Peg but hopefully with significantly improved tolerability. This could allow higher doses and longer spacing between injections.

It is interesting that part of the excitement over Ropeg is because might possibly slow progression. Is this changing the general view on Peg (which was that a minority of patients, perhaps as few as only 20%, get good molecular response but no proof that this slows progression)?

Betsywest profile image
Betsywest in reply to Paul123456

Thanks Paul for the explanation. It is looking very hopeful, I will keep my fingers crossed for this one I think & will be keeping a close eye.. Am so grateful for your posts.

CommonDaisy profile image
CommonDaisy

Hi Paul,

Thanks so much for sharing this. The video linked isn’t working for me. Could you please let me know the title of the video o I can search for it on YouTube?

Thanks again! :)

Paul123456 profile image
Paul123456 in reply to CommonDaisy

Try searching for Verstovsek ropeginterferon 2018 mpn asia.

The link I posted does appear to work (for once!) so problem might be your end

Best Paul

Wyebird profile image
Wyebird

Hi Paul, I’m afraid I can’t get the video to work but will follow the advice you have posted to commondaisy.

I look forward to seeing it.

Paul123456 profile image
Paul123456

Try this link

youtu.be/nDVFEnYu7xk

Otherwise google

Proud/Continue-PV Ropeginterferon MPN Asia Dr Srdan Verstovsek 2018

Best Paul

Paul123456 profile image
Paul123456

This should work, now on MPN Foundation

mpnresearchfoundation.org/A...

Tintins profile image
Tintins

Thank you! A very interesting study.

Bluetop profile image
Bluetop

Thanks Paul. It does sound positive. How is your own interferon going?

Paul123456 profile image
Paul123456 in reply to Bluetop

Very well, thanks. Appears to be controlling my symptoms and no side effects. Get first bloods on Tues so will be interesting. Peg is just a less refined version of Ropeg so I’m hoping there is significant read across re molecular response.

Wish I’d started a bit earlier now.

You may also like...

FDA Rejects Ropeginterferon alfa-2b for Polycythemia Vera

company PharmaEssentia. Although their drug ropeginterferon alfa-2b is sold in the European Union...

FDA Issues Complete Response Letter for Ropeginterferon Alfa-2b for Polycythemia Vera

regarding the biologics license application for ropeginterferon alfa-2b-njft for the treatment of...

Ropeginterferon Alfa-2b listed as Preferred Treatment in Polycythemia Vera

Guidelines in Oncology have been revised to include ropeginterferon alfa-2b-njft as a preferred...

Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera

were the results? Over a lifetime, the model showed that patients who received ropeginterferon...

Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment

Discussion; The results in our study demonstrate that the new dosing regimen of 250-350-500 µg of...